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We isolated 45 Helicobacter pylori strains from 217 child patients. Resistance to clarithromycin, metronida-
zole, amoxicillin, and tetracycline was detected in 27%, 13%, 4%, and 0% of strains, respectively. The A2143G
mutation was the most prevalent (67%) among clarithromycin-resistant strains. In addition, strain genotyping
revealed a significant association between gastritis severity and the simultaneous presence of cagA, vacA s1m1,
iceA2, and babA2 genes.
Helicobacter pylori infection is found worldwide and consti-
tutes a public health concern in many countries. Previous ep-
idemiological studies have shown a high prevalence of H. pylori
infection in Brazil (2, 20, 24). H. pylori infection, generally
acquired in childhood, persists asymptomatically for decades in
most individuals.
Amoxicillin, tetracycline, metronidazole, and clarithromycin
are frequently used, combined with proton pump inhibitors or
bismuth salts, for the treatment of H. pylori infections (25).
However, antibiotic resistance is frequently associated with
eradication failure (3, 16). Resistance to metronidazole and
clarithromycin is population dependent, and several studies
suggest that clarithromycin resistance is higher in strains iso-
lated from children than in strains isolated from adults (10). In
Brazil, the prevalence of clarithromycin-resistant strains in
adults is reported to be from 7 to 10% (15, 18). However, little
is known about the prevalence of clarithromycin-resistant H.
pylori infection in Brazilian children.
The primary aims of this study were to determine the prev-
alence of clarithromycin-resistant H. pylori strains in children,
to identify those isolates via rapid methodology, and to exam-
ine the severity of gastritis caused by the antibiotic-resistant H.
pylori isolates. Metronidazole, amoxicillin, and tetracycline re-
sistance was also studied. Furthermore, the study aimed to
genotype the vacA and iceA genes and to detect the cagA gene
in gastric biopsy specimens, since recent studies found a high
frequency of cagA-positive and iceA2-positive strains as well as
a strain with the vacA signal region genotype s1 and middle
region sequence m1 among pediatric H. pylori isolates in Brazil
(6, 7, 11, 23). This is also the first investigation of babA2 gene
prevalence in Brazilian children.
A total of 217 consecutive child patients, aged 1 to 18 years
(mean age, 10 years) (105 girls and 112 boys), who underwent
upper gastrointestinal endoscopy for the evaluation of dyspep-
tic symptoms at the outpatient clinic of Pediatric Gastroenter-
ology at the Instituto da Crianc¸a, Faculdade de Medicina da
Universidade de Sa˜o Paulo, during 2008 and 2009 were in-
cluded. The study was approved by the Ethics Committee of
the University Hospital. Patients previously treated for H.
pylori infections were not included.
Gastric biopsy specimens were processed for histological
examination and evaluated according to the updated Sydney
system of classification and grading of gastritis (4).
Antral gastric specimens were transported in sodium thio-
glycolate broth (Difco, Detroit, MI) in an ice bath and ground
before submission to DNA extraction and PCR-restriction
fragment length polymorphism (PCR-RFLP) analysis with
primers specific to the H. pylori 23S rRNA gene (17). The
QIAmp tissue kit (Qiagen) was used for DNA extraction. Point
mutations related to clarithromycin resistance in the 23S
rRNA amplicon were investigated in all H. pylori isolates by
PCR-RFLP using BsaI and MboII enzymes (27). The vacA,
cagA, iceA, and babA2 genotypes were detected by PCR, as
described elsewhere (1, 9, 21, 26, 28). In each experiment, H.
pylori strain 26695 (ATCC 700392) was used as the positive-
control strain.
H. pylori strains were cultured on Belo Horizonte medium
(22) under microaerophilic atmosphere at 37°C for 3 to 7 days,
and the isolates were identified by Gram staining and biochem-
ical tests for oxidase, catalase, and urease production. Resis-
tance to clarithromycin, metronidazole, amoxicillin, and tetra-
cycline was determined by the disc diffusion method (Oxoid),
and MICs were determined by the Etest according to the
manufacturer’s recommendations (AB Biodisk, Solna, Swe-
den). An isolate was considered resistant to clarithromycin or
tetracycline if the MIC was 1 mg/liter and to metronidazole
or amoxicillin if the MIC was 4 mg/liter (19).
Data were analyzed by the two-tailed 2 test and Fisher exact
test. P values of 0.05 were considered statistically significant.
H. pylori was isolated in 45 (20.7%) of the 217 children; 12
(26.7%) of the 45 strains were clarithromycin resistant, 6
(13.3%) were metronidazole resistant, and 2 (4.4%) were
amoxicillin resistant. All cultured H. pylori strains were suscep-
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tible to tetracycline (Fig. 1). No histological differences were
observed between biopsy specimens with antibiotic-resistant
strains and those with susceptible strains. PCR-RFLP was per-
formed with all 12 clarithromycin-resistant isolates: 8 had the
23S rRNA A2143G point mutation, and 4 had the 23S rRNA
A2142G mutation.
Among the 45 H. pylori-infected children, 13 had mild
chronic gastritis, 28 had moderate chronic gastritis, 2 had
marked chronic gastritis, and 2 had normal gastric mucosa.
The percentage of H. pylori-infected children with chronic gas-
tritis was 95.5% (43 patients), while 4.4% of the children (2
patients) had normal mucosa (P  0.001).
vacA was detected in all 45 H. pylori-positive gastric biopsy
specimens. The vacA genotypes s1m1, s2m2, and s1m2 or s2m1
were found in 57.7, 33.3, and 4.4% of the specimens, respec-
tively. The iceA1 allele was detected in 9 (20%) and the iceA2
allele in 31 (68.9%) of the samples. Of the 45 H. pylori-positive
biopsy specimens, 28 (62%) were cagA positive and 38 (84.4%)
were babA2 positive. Correlation of histopathology results with
vacA, cagA, and iceA genotypes showed that vacA s1m1-,
cagA-, and iceA2-positive strains were more frequently found
in patients with moderate and marked gastritis (77%) than in
patients with mild gastritis (23%) (P  0.001). Interestingly, in
Slovenian children, vacA s1 and cagA were also shown to be
associated with more pronounced chronic gastritis (12). In
contrast, in Korean children, although vacA s1m1 cagA iceA1
was the predominant genotype, no association with gastritis
severity was observed (14).
In conclusion, we found a high incidence of clarithromycin-
resistant H. pylori strains (27%) in Brazilian children. Further-
more, we found an association between clarithromycin resis-
tance and either the vacA s1m1 (P  0.007) or the iceA2 (P 
0.038) genotype. The high level of clarithromycin resistance
among strains from children compared to adults (15, 18) sug-
gests the importance of susceptibility testing, especially in Bra-
zilian children. All together, these data stress the relevance of
susceptibility testing and genotyping for establishing antibiotic
treatment in pediatric H. pylori infection.
In our study, PCR-RFLP proved to be a rapid and accurate
method for the detection of clarithromycin resistance gene
mutation directly in gastric biopsy samples. Only a few groups
have studied mutations involved in clarithromycin resistance in
strains obtained from children, and their results are similar to
those obtained in our study (5, 13, 29).
Our data also demonstrate an association between H. pylori
infection and gastritis in Brazilian children. In addition, we
confirmed the reported association of infection with vacA s1m1
cagA iceA2-positive H. pylori strains and gastritis severity (6, 11,
23). Furthermore, a high frequency of babA2 was found among
H. pylori isolates. Previous studies of adults in Brazil reported
a high prevalence of babA2-positive strains from patients with
different upper gastrointestinal diseases (8). The high inci-
dence of babA2 in H. pylori Brazilian isolates suggests that this
gene could be a useful marker for identifying patients with a
high risk of H. pylori infection in Brazil.
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